Picture of Hisamitsu Pharmaceutical Co logo

4530 Hisamitsu Pharmaceutical Co Income Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Annual income statement for Hisamitsu Pharmaceutical Co, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.

2019
February 28th
2020
February 29th
2021
February 28th
2022
February 28th
2023
February 28th
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue143,408140,992114,510120,193128,330
Cost of Revenue
Gross Profit88,68187,60469,17370,06772,700
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses121,269117,785103,837111,136116,942
Operating Profit22,13923,20710,6739,05711,388
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes25,67326,15512,19712,95616,113
Provision for Income Taxes
Net Income After Taxes19,37918,9119,4339,86312,126
Minority Interest
Net Income Before Extraordinary Items
Net Income19,20518,6949,2519,65911,743
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income19,20418,6949,2509,65811,742
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS232223111122147
Dividends per Share
Special Dividends per Share